Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6671475 | 7347580 | I | 6671475-2 | 20100329 | 20100330 | 20100407 | EXP | JP-MERCK-1004USA00141 | MERCK HUMAN HEALTH DIVISION | 84 | YR | M | Y | 20100407 | MD | JAPAN |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
6671475 | 1013460186 | PS | JANUVIA | 1 | ORAL | 21995 | |||||
6671475 | 1013460187 | SS | ASPIRIN | 1 | ORAL | ||||||
6671475 | 1013460188 | SS | PROTECADIN | 2 | ORAL | ||||||
6671475 | 1013460189 | SS | ACTOS | 1 | ORAL | ||||||
6671475 | 1013460190 | SS | AMARYL | 1 | ORAL | ||||||
6671475 | 1013460191 | SS | LIVALO | 1 | ORAL |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
6671475 | 1013460186 | HYPERGLYCAEMIA |
6671475 | 1013460187 | THROMBOSIS PROPHYLAXIS |
6671475 | 1013460189 | HYPERGLYCAEMIA |
6671475 | 1013460190 | HYPERGLYCAEMIA |
6671475 | 1013460191 | HYPERLIPIDAEMIA |
Outcome of event
Event ID | OUTC COD |
---|---|
6671475 | HO |
6671475 | LT |
Reactions reported
Event ID | PT |
---|---|
6671475 | MYOCARDIAL INFARCTION |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
6671475 | 1013460186 | 20100121 | |||
6671475 | 1013460187 | 20081211 | |||
6671475 | 1013460188 | 20081211 | |||
6671475 | 1013460189 | 20081211 | |||
6671475 | 1013460190 | 20081211 | |||
6671475 | 1013460191 | 20081211 |